Kangmei Pharmaceutical Co Ltd (600518.SS)
20 Apr 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|45||1997||Chairman of the Board, General Manager|
|44||1997||Vice Chairman of the Board, Deputy General Manager|
|42||2001||Chief Financial Officer|
|54||2008||Deputy General Manager|
|48||2017||Deputy General Manager|
- BRIEF-Kangmei Pharmaceutical issues 2018 first tranche super short-term financing notes worth 1.5 bln yuan
- BRIEF-Kangmei Pharma Signs Agreement To Set Up Hospital With Partners
- BRIEF-Kangmei Pharmaceutical to acquire 80 pct stake in Huizhou-based pharmaceutical firm for 20.8 mln yuan
- BRIEF-Kangmei Pharmaceutical to invest 50 mln yuan to set up wholly owned medical appliances firm
- BRIEF-Kangmei Pharmaceutical in deal to invest 5 bln yuan in Guizhou